+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genotyping Market - Global Forecast 2026-2032- Product Image
Genotyping Market - Global Forecast 2026-2032- Product Image
New

Genotyping Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5454849
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The genotyping market is evolving rapidly, driven by innovation in molecular biology, increased data integration, and changing operational priorities across diagnostics, agriculture, and life sciences research. Senior decision-makers now face a dynamic environment shaped by converging technology options, regulatory changes, and the need for agile investments.

Market Snapshot

The Genotyping Market grew from USD 154.38 billion in 2025 to USD 165.76 billion in 2026. Projections indicate it will maintain a robust compound annual growth rate (CAGR) of 9.01%, reaching USD 282.48 billion by 2032. This market trajectory reflects sustained cross-sector adoption as genotyping capabilities become integral to clinical diagnostics, precision agriculture, and translational research.

Scope & Segmentation

  • Technology Modalities: Microarrays, polymerase chain reaction (PCR) methods, and next-generation sequencing platforms are central. Within microarrays, comparative genomic hybridization and SNP arrays support large-scale variant detection. PCR divides between digital and real-time approaches. Sequencing solutions split into exome, targeted, whole-genome, and legacy Sanger workflows, each addressing different depth, cost, and throughput requirements.
  • Application Areas:
    • Agriculture targets crop and livestock improvement through genomic prediction and marker-assisted selection.
    • Clinical diagnostics focuses on cancer profiling and infectious disease detection, where reliability and compliance are critical.
    • Research settings drive demand for gene expression analysis and investigation of genetic variation with an emphasis on flexibility.
  • End-User Segments: Academic and research institutes, pharmaceutical and biotechnology companies, and diagnostic laboratories, each with unique buy cycles and operational expectations.
  • Sample Types: Human, animal, plant, and microbial samples, each introducing distinct pre-analytical, extraction, and validation needs that affect kit and workflow design.
  • Regional Markets:
    • Americas exhibit diverse payer systems and fast clinical uptake.
    • Europe, Middle East & Africa present harmonized but varying infrastructure with an emphasis on robust installation and support.
    • Asia-Pacific is distinguished by rapid public and commercial expansion as well as strong manufacturing initiatives.

Key Takeaways

  • The genotyping market integrates molecular platforms with computational analytics, shifting from single-marker tests to multi-platform, high-throughput workflows suited for both discovery and routine analysis.
  • Hybrid workflows combining sequencing and targeted assays are becoming standard, enabling labs to address both high-resolution discovery and scalable clinical or agricultural screening needs.
  • Regulatory scrutiny drives investment in analytical validation, reporting standards, and interoperable data infrastructure; successful organizations align procurement and strategy with these heightened requirements.
  • Laboratories and organizations must consider regulatory compliance, sample variability, and downstream data analytics in tandem when selecting genotyping platforms and structuring contracts with suppliers.
  • Strategic partnerships between technology vendors and service providers are essential, facilitating broader adoption and co-investment in validation, while flexible supply agreements help counter supply chain volatility.
  • Operational agility—through modular automation, data governance, and scalable analytics—enables adaptation to emerging policy, market, and technology shifts across global regions.

Tariff Impact

Recent tariff measures in the United States have introduced new operational complexities for instrument procurement and supply chain management within the genotyping sector. Elevated import duties require procurement teams to diversify supplier networks, secure local stocking agreements, and pursue supply stabilization strategies. Manufacturers are reconsidering regional production and distribution models, prompting organizations to incorporate tariff scenarios into capital planning and vendor evaluations. These developments underscore the strategic importance of resilience and flexibility in the face of evolving trade policies.

Methodology & Data Sources

This analysis utilizes a reproducible mixed-methods approach. Primary research included interviews with laboratory directors, procurement staff, instrument engineers, and scientists, capturing operational challenges and vendor dynamics. Robust secondary research involved scientific literature, regulatory documents, patent disclosures, technical manuals, and clinical trial databases. Findings were cross-validated and independently reviewed, with scenario analysis assessing supply chain and policy risks.

Why This Report Matters

  • Provides actionable insights for technology adoption, product development, and procurement strategy aligned to current regulatory and operational realities.
  • Delivers segment-level analysis to inform product prioritization and go-to-market approaches for diverse user bases and geographic regions.
  • Enables organizations to benchmark resilience, scalability, and data interoperability strategies essential for sustained success in genotyping.

Conclusion

The genotyping market is defined by increasingly sophisticated, modular solutions and a shift toward hybrid, interoperable workflows. Strategic investments in technology, partnerships, and operational resilience will position stakeholders for continued impact across clinical, agricultural, and research domains.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Genotyping Market, by Sample Type
8.1. Animal
8.2. Human
8.3. Microbial
8.4. Plant
9. Genotyping Market, by Technology
9.1. Microarray
9.1.1. Comparative Genomic Hybridization
9.1.2. Snp Array
9.2. Pcr
9.2.1. Digital
9.2.2. Real Time
9.3. Sequencing
9.3.1. Next Generation
9.3.1.1. Exome
9.3.1.2. Targeted
9.3.1.3. Whole Genome
9.3.2. Sanger
10. Genotyping Market, by Application
10.1. Agriculture
10.1.1. Crop Improvement
10.1.2. Livestock Breeding
10.2. Clinical Diagnostics
10.2.1. Cancer Profiling
10.2.2. Pathogen Detection
10.3. Research
10.3.1. Gene Expression Analysis
10.3.2. Genetic Variation Studies
11. Genotyping Market, by End User
11.1. Academic And Research Institutes
11.2. Diagnostic Laboratories
11.3. Pharmaceutical And Biotechnology Companies
12. Genotyping Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Genotyping Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Genotyping Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Genotyping Market
16. China Genotyping Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Agilent Technologies, Inc.
17.6. BGI Genomics Co., Ltd.
17.7. Bio-Rad Laboratories, Inc.
17.8. Danaher Corporation
17.9. Eurofins Scientific SE
17.10. F. Hoffmann-La Roche Ltd
17.11. Illumina, Inc.
17.12. Merck KGaA
17.13. Oxford Nanopore Technologies plc
17.14. Pacific Biosciences of California, Inc.
17.15. PerkinElmer, Inc.
17.16. QIAGEN N.V.
17.17. Revvity, Inc.
17.18. Standard BioTools Inc.
17.19. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL GENOTYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GENOTYPING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GENOTYPING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GENOTYPING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GENOTYPING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES GENOTYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA GENOTYPING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GENOTYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GENOTYPING MARKET SIZE, BY ANIMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GENOTYPING MARKET SIZE, BY ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GENOTYPING MARKET SIZE, BY ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GENOTYPING MARKET SIZE, BY HUMAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GENOTYPING MARKET SIZE, BY HUMAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GENOTYPING MARKET SIZE, BY HUMAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GENOTYPING MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GENOTYPING MARKET SIZE, BY MICROBIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GENOTYPING MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GENOTYPING MARKET SIZE, BY PLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GENOTYPING MARKET SIZE, BY PLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GENOTYPING MARKET SIZE, BY PLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GENOTYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GENOTYPING MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GENOTYPING MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GENOTYPING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GENOTYPING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GENOTYPING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GENOTYPING MARKET SIZE, BY SNP ARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GENOTYPING MARKET SIZE, BY SNP ARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GENOTYPING MARKET SIZE, BY SNP ARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GENOTYPING MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GENOTYPING MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GENOTYPING MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GENOTYPING MARKET SIZE, BY DIGITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GENOTYPING MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GENOTYPING MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GENOTYPING MARKET SIZE, BY REAL TIME, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GENOTYPING MARKET SIZE, BY REAL TIME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GENOTYPING MARKET SIZE, BY REAL TIME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GENOTYPING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GENOTYPING MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GENOTYPING MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GENOTYPING MARKET SIZE, BY NEXT GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GENOTYPING MARKET SIZE, BY NEXT GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GENOTYPING MARKET SIZE, BY NEXT GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GENOTYPING MARKET SIZE, BY EXOME, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GENOTYPING MARKET SIZE, BY EXOME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GENOTYPING MARKET SIZE, BY EXOME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GENOTYPING MARKET SIZE, BY TARGETED, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GENOTYPING MARKET SIZE, BY TARGETED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GENOTYPING MARKET SIZE, BY TARGETED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GENOTYPING MARKET SIZE, BY WHOLE GENOME, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GENOTYPING MARKET SIZE, BY WHOLE GENOME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GENOTYPING MARKET SIZE, BY WHOLE GENOME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GENOTYPING MARKET SIZE, BY SANGER, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GENOTYPING MARKET SIZE, BY SANGER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GENOTYPING MARKET SIZE, BY SANGER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GENOTYPING MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GENOTYPING MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GENOTYPING MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENOTYPING MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENOTYPING MARKET SIZE, BY CROP IMPROVEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENOTYPING MARKET SIZE, BY CROP IMPROVEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GENOTYPING MARKET SIZE, BY LIVESTOCK BREEDING, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GENOTYPING MARKET SIZE, BY LIVESTOCK BREEDING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GENOTYPING MARKET SIZE, BY LIVESTOCK BREEDING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GENOTYPING MARKET SIZE, BY CANCER PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GENOTYPING MARKET SIZE, BY CANCER PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GENOTYPING MARKET SIZE, BY CANCER PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GENOTYPING MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GENOTYPING MARKET SIZE, BY PATHOGEN DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GENOTYPING MARKET SIZE, BY PATHOGEN DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GENOTYPING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENOTYPING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GENOTYPING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL GENOTYPING MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL GENOTYPING MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL GENOTYPING MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL GENOTYPING MARKET SIZE, BY GENETIC VARIATION STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL GENOTYPING MARKET SIZE, BY GENETIC VARIATION STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL GENOTYPING MARKET SIZE, BY GENETIC VARIATION STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GENOTYPING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GENOTYPING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GENOTYPING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL GENOTYPING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL GENOTYPING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL GENOTYPING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GENOTYPING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL GENOTYPING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL GENOTYPING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS GENOTYPING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. EUROPE GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 149. EUROPE GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 151. EUROPE GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 152. EUROPE GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 155. EUROPE GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 156. EUROPE GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 157. EUROPE GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. AFRICA GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 172. AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 173. AFRICA GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 175. AFRICA GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 176. AFRICA GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 177. AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. AFRICA GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 179. AFRICA GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 180. AFRICA GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 181. AFRICA GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL GENOTYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. ASEAN GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. ASEAN GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 197. ASEAN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. ASEAN GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 200. ASEAN GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 201. ASEAN GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 202. ASEAN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. ASEAN GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 204. ASEAN GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 205. ASEAN GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 206. ASEAN GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. GCC GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. GCC GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 209. GCC GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 210. GCC GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 211. GCC GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 212. GCC GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 213. GCC GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 214. GCC GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. GCC GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 216. GCC GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 217. GCC GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 218. GCC GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. BRICS GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. BRICS GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 233. BRICS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 234. BRICS GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 235. BRICS GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 236. BRICS GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 237. BRICS GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 238. BRICS GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. BRICS GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 240. BRICS GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 241. BRICS GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 242. BRICS GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. G7 GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. G7 GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 245. G7 GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 246. G7 GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 247. G7 GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 248. G7 GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 249. G7 GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 250. G7 GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. G7 GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 252. G7 GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 253. G7 GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 254. G7 GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 255. NATO GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. NATO GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 257. NATO GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 258. NATO GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 259. NATO GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 260. NATO GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 261. NATO GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 262. NATO GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 263. NATO GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 264. NATO GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 265. NATO GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 266. NATO GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES GENOTYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. CHINA GENOTYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 281. CHINA GENOTYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 282. CHINA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 283. CHINA GENOTYPING MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
TABLE 284. CHINA GENOTYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 285. CHINA GENOTYPING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 286. CHINA GENOTYPING MARKET SIZE, BY NEXT GENERATION, 2018-2032 (USD MILLION)
TABLE 287. CHINA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 288. CHINA GENOTYPING MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
TABLE 289. CHINA GENOTYPING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 290. CHINA GENOTYPING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 291. CHINA GENOTYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Genotyping market report include:
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Revvity, Inc.
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 165.76 Billion
Forecasted Market Value ( USD ) by 2032 $ 282.48 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

SNP Genotyping and Analysis Market Report 2025 - Product Image

SNP Genotyping and Analysis Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Single Nucleotide Polymorphism Genotyping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Single Nucleotide Polymorphism Genotyping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 182 Pages
  • Global
From
Single Nucleotide Polymorphism (Snp) Genotyping Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Single Nucleotide Polymorphism (Snp) Genotyping Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
SNP Genotyping and Analysis - Global Strategic Business Report - Product Image

SNP Genotyping and Analysis - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Genotyping Assay Market - Global Forecast 2026-2032 - Product Image

Genotyping Assay Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From

About the Genotyping Market

The genotyping market is a subset of the genomics industry that focuses on the identification of genetic variations between individuals. It is used to identify genetic markers associated with diseases, to determine the risk of developing certain conditions, and to identify the most effective treatments for a given individual. Genotyping is also used in the development of personalized medicine, which is tailored to the individual’s genetic makeup. Genotyping technologies include next-generation sequencing, microarrays, and PCR-based methods. The genotyping market is expected to grow due to the increasing demand for personalized medicine, the development of new technologies, and the increasing availability of genomic data. Additionally, the increasing prevalence of chronic diseases and the need for more accurate diagnosis and treatment are expected to drive the growth of the genotyping market. Some companies in the genotyping market include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and PerkinElmer. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.